Welcome to the Office of Research and Diversity Training (ORDT)
The mission of the Office of Diversity Recruitment and Research Training (ORDT) is to recruit and provide research training opportunities to scholars from populations that have traditionally been underrepresented in biomedical science, including underrepresented minorities, first generation students, and individuals with disabilities.
1. To develop and coordinate targeted recruitment strategies to attract a diverse group of competitive trainees.
2. To provide academic and professional career development training and social support to scholars who are underrepresented in the sciences.
3. To develop partnerships with faculty and administrators across the seven schools within the university for recruitment, retention, and support of scholars with diverse backgrounds.
4. To establish and enhance partnerships with other institutions of higher learning to recruit candidates.
Underrepresented student enrollment: ~170 students in PhD programs, ~10 post baccalaureate scholars, ~ 45 summer interns
Latest Penn Medicine News
Using Race to Diagnose Anemia During Pregnancy May Increase Anemia at Delivery and Poor Outcomes
Thursday, July 22, 2021
Clinicians should not take race into account when diagnosing anemia in pregnant patients and pursuing interventions, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
City-Funded Housing Repairs in Low-Income Neighborhoods Associated with Drop in Crime
Wednesday, July 21, 2021
“We can now add structural home repairs to the growing list of place-based neighborhood interventions with strong evidence that they can help reduce violent crime,” said lead author Eugenia South, MD, MSHP.
Spinal Fluid Biomarkers Detect Neurodegeneration, Alzheimer’s Disease in Living Patients
Tuesday, July 20, 2021
“CSF biomarkers work similarly to a pregnancy test, offering a simple positive or negative result when enough of a substance is detected. But like a pregnancy test, biomarkers for Alzheimer’s disease can provide false negatives or positives,” said lead investigator Katheryn A.Q. Cousins, PhD.